ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
0
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
4,485
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Cost effectiveness of insulin glargine/lixisenatide for patients with type 2 diabetes inadequately controlled on basal insulin in South Korea
Author(s):
H.-Y. Park
,
S-N An
,
S.-S. Park
,
Hae-Young Lopilly Park
,
Sena An
,
Susan Park
,
Dong-Ha Kim
,
Hye Kim
,
Jeong-Mi Kwon
,
Jin-Won Kwon
Publication date:
2019
Journal:
Yakhak Hoeji
Read this article at
ScienceOpen
Publisher
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
GLUT4 biology
Author and article information
Journal
DOI::
10.17480/psk.2019.63.1.1
ScienceOpen disciplines:
Endocrinology & Diabetes
Data availability:
ScienceOpen disciplines:
Endocrinology & Diabetes
Comments
Comment on this article
Sign in to comment
scite_
Similar content
4,485
Long-term cost-effectiveness of two GLP-1 receptor agonists for the liraglutide versus lixisenatide
Authors:
B Hunt
,
N Kragh
,
CC McConnachie
…
“Lyxumia® (lixisenatide) One-Step Regimen as Effective as Two-Step Regimen in Improving Glycemic Control in Type 2 Diabetes”
Authors:
Sanofi-Aventis
Augmentation of 1st‐phase insulin release with lixisenatide in non‐diabetic subjects
Authors:
R BECKER
,
J Stechl
,
C Kapitza
…
See all similar
Cited by
2
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus
Authors:
Jennifer Ken-Opurum
,
Sistla S. S. Srinivas
,
Divya Jain
…
Co-Formulations as the First Injectable in Type 2 Diabetes: A Review of Efficacy, Safety, and Implications in Clinical Practice
Authors:
Mathew John
,
Deepa Gopinath
,
Tittu Oommen
See all cited by